The efficacies of pefloxacin, fosfomycin, and both of these agents in combination against methicillin-resistant Staphylococcus aureus were assessed in a rat endocarditis model. The combination prevented emergence of the fosfomycin and pefloxacin resistance seen in 36 and 4%, respectively, of animals receiving either agent alone and was more effective than either agent in sterilizing cardiac vegetations.
Serious infections due to methicillin-resistant Staphylococcus aureus (MRSA) represent a major therapeutic challenge. At present there are few satisfactory alternatives to vancomycin for therapy of endocarditis caused by these organisms (21) . Among the fluoroquinolones which have shown promising activity against MRSA (5, 17, 23, 25 ), pefloxacin appears to be an attractive option for treatment of endocarditis because of excellent penetration into cardiac valve tissue (6, 8) , long serum half-life (16) , and feasibility of administration by both oral and parenteral routes. Although pefloxacin has been effective in some experimental MRSA infections (19, 22) , the emergence of resistance to pefloxacin among staphylococci has been noted both in vitro (3) and in vivo (27) . Emergence of resistant colonies also limits the utility of other antistaphylococcal antimicrobial agents, including fosfomycin, a relatively nontoxic drug which inhibits an early step in peptidoglycan synthesis (1, 10, 14) . Because antimicrobial combinations may suppress the emergence of drug-resistant populations and/or achieve inhibitory or bactericidal synergism, we investigated the efficacy of the pefloxacin-fosfomycin combination and of either drug alone in a rat model of endocarditis due to MRSA.
(This work was presented in part at the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy [C. Thauvin, J.-F. Lemeland, G. Humbert, and J.-P. Fillastre, Program Abstr. 26th Intersci. Conf. Antimicrob. Agents Chemother., abstr. no. 284, 1986].)
MRSA strain 72792 used throughout the study was a clinical isolate recovered in Rouen, France. The MIC of oxacillin was 64 pLg/ml by a standard broth macrodilution method in Mueller-Hinton broth (11) . Broth was supplemented with glucose 6-phosphate (25 ,ug/ml) for tests with fosfomycin (13) . Drug interactions were evaluated by macrodilution broth checkerboard titration with inocula of 106 CFU/ml. MICs were determined after 18 h of incubation at 37°C. Samples (0.01 ml) from clear tubes were streaked onto blood agar plates, permitting determination of MBCs at the 99.9% killing level (18 (20), with minor modifications as previously described (24) . Nonbacterial thrombotic endocarditis was created in male Wistar rats (180 to 220 g) by insertion of a polyethylene catheter across the aortic valve.
At 30 min after catheterization, 105 CFU of MRSA 72792 in saline was injected through the catheter, which was heat sealed and left in place throughout the experiment. At 24 h after catheter insertion, venous blood cultures were obtained. Only animals with both initial blood cultures positive for MRSA and correct placement of the catheter across the aortic valve (as established at autopsy) were included in the study. Animals were randomly assigned to one of the following four groups: (i) pefloxacin alone, (ii) fosfomycin alone, (iii) the two drugs in combination, and (iv) an untreated control. Treatment was begun 24 h after bacterial challenge and continued for 6 days. Pefloxacin (50 mg/kg every 12 h) was administered perorally. Fosfomycin (500 mg/kg per day) was delivered by continuous intravenous infusion through an indwelling jugular venous catheter as previously described (24) .
On day 2 of therapy, serum drug levels were measured by agar well diffusion (2) . Blood cultures were obtained on days 2 and 6 of therapy. Animals surviving 6 days of treatment were sacrificed 12 h after the last dose of pefloxacin and 4 h following discontinuation of fosfomycin. All cardiac vegetations from each animal were aseptically removed, weighed, and homogenized in saline to obtain colony counts. The lower limit of detection by this method was 3 log1o CFU/g. Data from animals which died before completion of therapy were included only if they had received at least 2 full days of therapy and if they had been refrigerated within 6 h of death. Susceptibilities of organisms persisting in cardiac vegetations were determined by disk diffusion techniques (4). Inocula were prepared from several randomly chosen colonies from each valve. Strains showing zones of inhibition smaller than those of the parent isolate were subjected to MIC testing. Strains were defined as resistant if the MICs of pefloxacin and fosfomycin were more than 4 and 32 ,ug/ml, ANTIMICROB. AGENTS CHEMOTHER. Sterile vegetations were assigned a value of 3.00 log1o CFU/g (the lower limit of detection) for computation of group means.
respectively. The chi-square test with Yates' correction was used for evaluatio'n of nominal data. Analysis of variance followed by comparison of means by the Bonferroni method was used for comparisons of bacterial titers within vegetations.
Pefloxacin and fosfomycin were bactericidal against MRSA 72792 with MBCs (=MICs)'of 0.25 and 4.0 ,ug/ml, respectively. In combination, pefloxacin and fosfomycin were synergistic with fractional inhibitory and bactericidal concentration indices of 0.31. Levels of both drugs in serum corresponded to concentrations clinically achievable in humans. These were (mean ± standard deviation, micrograms per milliliter): fosfomycin alone, 30 ± 7.2; fosfomycin in combination, 35 ± 9.7; pefloxacin alone, 6.5 ± 4.1 (peak) and 1.3 ± 1.0 (trough); pefloxacin in combination, 9.0 ± 5.5 (peak) and 1.5 ± 1.0 (trough). Differences between levels of either drug alone or in combination'were not statistically significant.
Survival to day 6 was significantly more frequent among treated animals than among controls (P < 0.03), but'the three treatment groups did not differ from each other in this respect ( Table 1) . The pefloxacin-fosfomycin combination was more effective than fosfomycin alone in eradicating bacteremia (P < 0.01) but not more effective than pefloxacin alone. Pefloxacin and fosfomycin alone were equally effective in sterilization of blood cultures. The combination was strikingly better than either drug alone in sterilizing cardiac vegetations (P < 0.001). Bacterial titers within vegetations from all treatment groups were significantly lower than those of controls (P < 0.001). The pefloxacin-fosfomycin combination was superior to either drug alone in reducing bacterial titers within cardiac vegetations (P < 0.05). Resistance to fosfomycin arose in 5 of 14 (36%) surviving animals with positive vegetation cultures; resistance to pefloxacin was seen in 1 of 27 (4%) animals treated with that drug alone. These differences were significant (P < 0.05). Resistance to either agent was not seen with combination therapy.
Previous studies of fluoroquinolones in experimental endocarditis due to MRSA have reported substantial efficacy of these agents in reducing bacterial titers within cardiac vegetations after only 3 to 5 days of therapy (7, 9, 12, 22) . In recent studies using rabbits, ciprofloxacin reduced bacterial titers to 3.37 log1o CFU/g (12) and 2.4 log1o CFU/g (7) within this time period. Sullam et al. (22) noted similar results with pefloxacin, which reduced bacterial titers to 3.06 log1o CFU/g. In our study, pefloxacin alone was notably less effective, with residual titers of 6.2 log1o CFU/g after 6 days of treatment. Reasons for this discrepancy are not clear. However, undetermined strain virulence factors may explain these differences in part. In the other studies cited, bacterial titers within vegetations remained at <9 log1o CFU/g in control animals, while in our study bacterial titers reached 10.3 log1o CFU/g in vegetations in untreated animals.
Despite the low rate of sterilization of cardiac vegetations among animals treated with pefloxacin alone, resistance in posttherapy isolates was encountered in only 1 of 27 rats. In contrast, resistance to fosfomycin occurred commonly (in 36% of rats) when that drug was used alone. Although plasmid-mediated resistance to fosfomycin by probable drug inactivation has been reported in members of the family Enterobacteriaceae (15) , in this setting it is more likely that resistance mechanisms involve impairment of intracellular uptake of the drug which may arise by chromosomal mutation (26) . Use of fosfomycin in combination with pefloxacin completely prevented the emergence of strains resistant to the former agent. Because of the low incidence of resistance to pefloxacin used alone, possible benefits of the combination in suppressing the in vivo emergence of resistance to pefloxacin could not be accurately assessed. Whether the greater efficacy of the combination derives from true bactericidal synergism or from suppression of resistant clones, pefloxacin-fosfomycin combinations deserve further investigation as potential alternatives to vancomycin in the therapy of infections due to these problem pathogens.
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